Adeno-associated-virus Rep sequences, vectors and viruses
AssigneeThe Research Foundation for The State University of New York
InventorsWadie F. Bahou, Patrick Hearing, Varsha Sitaraman
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Research Foundation for The State University of New York
InventorsWadie F. Bahou, Patrick Hearing, Varsha Sitaraman
Estimating the term…
The invention provides adeno-associated virus (AAV) replication (Rep) sequences. In one embodiment, the invention provides nucleotide sequences encoding a chimeric protein, wherein the encoded chimeric protein contains a wild type AAV Rep inhibitory amino acid sequence, and wherein the nucleotide sequences contain a scrambled and/or deoptimized polynucleotide sequence encoding the wild type AAV Rep inhibitory amino acid sequence. The invention provides vectors, cells, and viruses containing the invention's sequences. Also provided are methods for detecting portions of the AAV Rep inhibitory amino acid sequence, which reduce replication and/or infection and/or productive infection by viruses. The invention's compositions and methods are useful for site-specific integration and/or expression of heterologous sequences by recombinant adeno-associated virus (rAAV) vectors and by rAAV virus particles, such as hybrid viruses (e.g., Ad-AAV) comprising such vectors. The invention's compositions and methods find application in, for example, gene therapy and/or vaccines.
A method for detecting a portion of wild type AAV Rep inhibitory nucleotide sequence that reduces replication by a hybrid Adenovirus that contains said portion, comprising
Dependencies are inferred from the claim text.